Company Overview of REGENX Biosciences, LLC
REGENX Biosciences, LLC, a biopharmaceutical company, develops therapeutics and research tools based on adeno-associated viral (AAV) vectors. The company offers NAV, a gene delivery technology that includes recombinant adeno-associated viral vectors. Its technology is used for the treatment of metabolic disorders, muscle diseases, hematologic disorders, ocular diseases, and neurodegenerative disorders; and clinical trails in therapeutic areas, such as inherited diseases, CNS disorders, heart failure, and vaccines. The company also offers reagent services for various applications, including molecular therapies, understanding biological activity and target validation, creating disease models a...
1701 Pennsylvania Avenue, NW
Washington, DC 20006
Key Executives for REGENX Biosciences, LLC
Chief Executive Officer, President and Director
Vice President of Legal Affairs
Compensation as of Fiscal Year 2014.
REGENX Biosciences, LLC Key Developments
REGENXBIO Inc Appoints Luke M. Beshar as Board of Director
Apr 28 15
REGENXBIO Inc. announced that Luke M. Beshar has been appointed to its board of directors effective April 15, 2015. Mr. Beshar will serve as the chairman of REGENXBIO's audit committee. Mr. Beshar brings more than 35 years of leadership experience to REGENXBIO's board. Most recently, he was Executive Vice President and Chief Financial Officer at NPS Pharmaceuticals Inc. Prior to NPS, Mr. Beshar served in leadership positions and as chief financial officer for organizations including Cambrex Corporation, Dendrite International, Expanets Inc., PNY Technologies Inc., WSR Corporation, The Genlyte Group Inc., Bairnco Corporation and Arthur Andersen & Co.
REGENX Biosciences, LLC Presents at 3rd Annual Regen Med Investor Day, Mar-25-2015 01:00 PM
Feb 28 15
REGENX Biosciences, LLC Presents at 3rd Annual Regen Med Investor Day, Mar-25-2015 01:00 PM. Venue: Metropolitan Club, One East 60th Street, New York, NY 10022, United States. Speakers: Kenneth T. Mills, Chief Executive Officer, President and Director.
REGENX Biosciences, LLC Presents at Boston Biotech Conferences LLC's The East Meets West CEO conference, Jan-11-2015 01:40 PM
Dec 3 14
REGENX Biosciences, LLC Presents at Boston Biotech Conferences LLC's The East Meets West CEO conference, Jan-11-2015 01:40 PM. Venue: Four Seasons Hotel, 757 Market St, San Francisco, CA 94103, United States. Speakers: Kenneth T. Mills, Chief Executive Officer, President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions